Ignite Creation Date:
2025-12-24 @ 7:57 PM
Ignite Modification Date:
2026-02-09 @ 4:32 PM
Study NCT ID:
NCT06558604
Status:
RECRUITING
Last Update Posted:
2025-01-27
First Post:
2024-07-24
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase II Study Evaluating Glofitamab in Combination With Venetoclax Plus Zanubrutinib or Venetoclax Alone in Subjects With Untreated or Relapsed/Refractory High-risk Mantle-cell Lymphoma
Sponsor:
The Lymphoma Academic Research Organisation
Organization: